Abiopharma

(30% Negative) ACLARIS THERAPEUTICS, INC. (ACRS) Reports Q2 2026 Financial Results

(75% Positive) GP-ACT III ACQUISITION CORP. (GPATW) Announces Business Combination

(30% Negative) RAPPORT THERAPEUTICS, INC. (RAPP) Reports Q2 2026 Financial Results

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-210772 <b>Size:</b> 729 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012430 <b>Size:</b> 1 MB

Stack Capital Group Inc. Reports Q1-2026 Financial Results

Nuveen Churchill Direct Lending Corp. Announces First Quarter 2026 Results

Americold Realty Trust, Inc. and EQT Announce a $1.3 Billion North American Cold Storage Joint Venture

Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

(30% Negative) CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Reports Q2 2026 Financial Results

Opening of Trading On Friday, May 08 2026-FOX B2

(99% Neutral) ROCKWELL MEDICAL, INC. (RMTI) Files Form 8-K

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Directors Interest

(99% Neutral) SHAKE SHACK INC. (SHAK) Files Form 8-K

(99% Neutral) NEXMETALS MINING CORP. (NEXM) Files Form 8-K